Bruker BioSpin Corporation Novel MRI CryoProbe(TM) Significantly Increases Sensitivity Of In-Vivo Animal Imaging

SEATTLE--(BUSINESS WIRE)--May 8, 2006--Bruker BioSpin's pioneering CryoProbe(TM) technology has now been implemented for in-vivo animal MRI at 9.4 Tesla. Imaging and spectroscopy applications on mouse brain have demonstrated improvements in signal-to-noise ratio (SNR) of about 100%, or a factor of 2. Compared to the corresponding standard room temperature MRI coils, the performance of the new MRI CryoProbe leads either to an increase in imaging resolution and quality, or to a reduction in the total scan time by a factor of 4.

Back to news